$MATN Mateon Therapeutics (OTCQB: MATN) to Develop its OT-101, a Phase 3 Clinical Drug Candidate, Initially Against COVID-19    $CYDY $AZN $BBIO $PFE $RHHBY $CANF $EPIX $MRK $GNCA $SYBX   #CoronaVirus #Covid19  #HotStocks #StockMarket #Daytrade #Profit